ABSTRACT
This chapter focuses on issues concerning missing data in clinical trials intended to support regulatory applications for drugs, medical devices, and biologics. Although many of the issues regarding missing data are similar in many contexts, several aspects of the regulatory setting have particular bearing on how missing data are handled. Therefore, this chapter begins with a brief review of clinical trials and the factors specific to the regulatory setting that influence the handling of missing data.
